Search
for
Sort by
Research 31–60 of 327
- 1. Medical Practice; Therapy; Adverse Reactions
- Trends in dermatological presentations at the emergency department of a tertiary hospital in Singapore: a 4-year analysis pre- and during COVID-19
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Isoniazid-induced alopecia
- Herbal Treatment for Dermatologic Disorders
- Mixing the Old with the New: Drug Repurposing for Immune Deficiency in the Era of Precision Medicine and Pediatric Genomics
- Frequency of Childhood Dermatological Diseases: An Analysis of 8551 Cases
- Secondary cicatricial and other permanent alopecias
- Alopecia
- Dermatolojik Problemler ve COVID-19
- JAK inhibitors and alopecia areata
- Farmácia Lusitana, Vila do Conde e nos Serviços Farmacêuticos do Hospital CUF, Porto
- Corticosteroids for the treatment of Duchenne muscular dystrophy
- Mucocutaneous reactions to chemotherapy
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Dermatoses of pregnancy
- Herbal Therapy in Dermatology
- Microneedles as the technique of drug delivery enhancement in diverse organs and tissues
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Graft-versus-host disease
- Autoimmunity and autoimmune co-morbidities in psoriasis
- Acquired scalp alopecia. Part II: A review
- Skin disease in pregnancy
- Cetuximab-Associated Elongation of the Eyelashes
- Idiopathic CD4+ T-lymphocytopenia
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost
- Teriflunomide in multiple sclerosis: an update
- Erosive pustular dermatosis of the scalp: a multicentre study